QUOTED. July 20, 2018. Kathie Bardwell.
Sterilization and decontamination technology firm Steris Corp. had two of its facilities appraised under a voluntary US FDA pilot program that aims to assess device-makers' manufacturing maturity and capability. See what Kathie Bardwell, VP and chief compliance officer for Steris, said about it here.
"In each [appraisal, workers] felt really good that they could talk about what they do for a living, explore things that maybe they know they don’t do really well, or things they have a problem with, and collectively talk about what they might do to improve it." –Kathie Bardwell, VP and chief compliance officer, Steris Corp.
- Find out more: Boston Scientific, Edwards Lifesciences, Baxter Used CMMI To Measure Their Manufacturing Capability. Here's What They Said About The Experience
Click here for a free trial of Medtech Insight